Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Bin Ke
Observed names:
B Ke,
B. Ke
Institutions:
Tianjin Medical University Cancer Institute and Hospital,
Tianjin Medical University
Observed institutions:
Tianjin Medical University Cancer Institute and Hospital,
Shangqiu First People's Hospital,
Tianjin Medical University,
East China Normal University
ORCID:
0000-0001-5629-9011
Observed ORCID:
0000-0001-5629-9011
OpenAlex ID:
A5103202430
A DNA-based hydrogel for exosome separation and biomedical applications
2023
·
Jianpu Tang
, Xuemei Jia
, et al.
·
Proceedings of the National Academy of Sciences
·
148
The role of preoperative neutrophil–lymphocyte and platelet–lymphocyte ratio in patients after radical resection for gastric cancer
2014
·
Nan Jiang
, Jing-Yu Deng
, et al.
·
Biomarkers
·
83
Sonic Hedgehog/Gli1 Signaling Pathway Regulates Cell Migration and Invasion via Induction of Epithelial-to-mesenchymal Transition in Gastric Cancer
2020
·
Bin Ke
, Xiao-Na Wang
, et al.
·
Journal of Cancer
·
44
PDF
Incorporation of perineural invasion of gastric carcinoma into the 7th edition tumor–node–metastasis staging system
2014
·
Nan Jiang
, Jing-Yu Deng
, et al.
·
Tumor Biology
·
42
Overexpression of stathmin 1 is associated with poor prognosis of patients with gastric cancer
2013
·
Bin Ke
, Liang-Liang Wu
, et al.
·
Tumor Biology
·
33
PERSIST: A multicenter, randomized phase II trial of perioperative oxaliplatin and S-1 (SOX) with or without sintilimab in resectable locally advanced gastric/gastroesophageal junction cancer (GC/GEJC).
2023
·
Xuewei Ding
, Xuejun Wang
, et al.
·
Journal of Clinical Oncology
·
30
Prognostic Value of the Lymph Node Ratio in Stage III Gastric Cancer Patients Undergoing Radical Resection
2014
·
Bin Ke
, Xi-Na Song
, et al.
·
PLoS ONE
·
28
PDF
Current status of lymph node dissection in gastric cancer
2021
·
Bin Ke
, Han Liang
·
Chinese Journal of Cancer Research
·
27
DNA Nanotechnology‐Engineered Supramolecular Hydrogel Biosensor for Cancer Diagnosis via Extracellular Vesicles
2025
·
Jianpu Tang
, Zhen Cui
, et al.
·
Advanced Functional Materials
·
25
PDF
Node-extranodal soft tissue stage based on extranodal metastasis is associated with poor prognosis of patients with gastric cancer
2014
·
Nan Jiang
, Jing-Yu Deng
, et al.
·
Journal of Surgical Research
·
24
Prognostic Value Analysis of Mutational and Clinicopathological Factors in Non-Small Cell Lung Cancer
2014
·
Chenguang Li
, Ligang Hao
, et al.
·
PLoS ONE
·
22
PDF
Perioperative sintilimab combination with SOX for resectable locally advanced gastric/gastroesophageal junction cancer(GC/GEJC): Initial findings of a single-arm phase II trial.
2022
·
Xuewei Ding
, Bin Li
, et al.
·
Journal of Clinical Oncology
·
17
Exploring the molecular characteristics of the malignant potential of gastric adenocarcinoma with enteroblastic differentiation
2023
·
Yong Wang
, Xiyin Wei
, et al.
·
Histopathology
·
16
Clinical significance of Stathmin1 expression and epithelial‑mesenchymal transition in curatively resected gastric cancer
2018
·
Bin Ke
, Xiao‑Fan Guo
, et al.
·
Molecular and Clinical Oncology
·
15
PDF
Drug-tolerant persister cancer cells
2023
·
Pengliang Wang
, Bin Ke
, et al.
·
Journal of the National Cancer Center
·
9
Intraperitoneal Chemotherapy Using Fluorouracil Implants Combined With Radical Resection and Postoperative Adjuvant Chemotherapy for Stage III Gastric Cancer: A Multi-Center, Randomized, Open-Label, Controlled Clinical Study
2021
·
Yan Xu
, Rupeng Zhang
, et al.
·
Frontiers in Oncology
·
9
PDF
A Smart DNA Network-Based Diagnostic System for Enrichment and Detection of Circulating Tumor Cells in Cancer Liquid Biopsy
2025
·
Jing Wang
, Jianpu Tang
, et al.
·
Analytical Chemistry
·
8
Clinical landscape and prognosis of patients with gastric cancer liver metastases: A nation-wide multicenter cohort study in China (RECORD study)
2023
·
Yunhe Gao
, Hongqing Xi
, et al.
·
中国科学通报:英文版
·
8
Oncogenic and immunological role of EDIL3 in human tumours: From pan-cancer analysis to validation in gastric cancer
2024
·
Bin Ke
, Peng Jin
, et al.
·
Heliyon
·
7
CO-STAR: Surgical conversion feasibility trial of sintilimab (PD-1 inhibitor) combined with Nab-PTX, S-1 and apatinib for the first-line treatment of stage IV gastric cancer (GC).
2021
·
Qiang Xue
, Baogui Wang
, et al.
·
Journal of Clinical Oncology
·
7
[Prognostic value of a predictive model comprising preoperative inflammatory response and nutritional indexes in patients with gastric cancer].
2023
·
L L Wu
, M Z Cai
, et al.
·
PubMed
·
6
Conversion therapy with sintilimab combined with chemotherapy and apatinib in stage IV gastric cancer
2025
·
Yong Liu
, Qiang Xue
, et al.
·
International Journal of Cancer
·
5
PDF
[Analysis of clinicopathological characteristics and prognosis on 42 patients with primary gastric adenosquamous cell carcinoma].
2017
·
Bin Li
, Lin Sun
, et al.
·
PubMed
·
5
2118P Perioperative sintilimab plus oxaliplatin and S-1 (SOX) versus SOX alone in resectable locally advanced gastric cancer/gastroesophageal junction cancer (GC/GEJC): A multicenter randomized phase II study (PERSIST)
2025
·
X. Ding
, J. Chai
, et al.
·
Annals of Oncology
·
3
151P CO-STAR: Surgical conversion feasibility trial of sintilimab (PD-1 inhibitor) combined with doublet chemotherapy (Nab-PTX & S-1) and apatinib (anti-angiogenic TKI) for the first-line treatment of stage IV gastric cancer (GC)
2021
·
Q. Xue
, B. Wang
, et al.
·
Annals of Oncology
·
3
Show more works
View as search
Works count:
47
Citation count:
636
H-index:
14
I10-index:
14
Year
Topic
Type